293 related articles for article (PubMed ID: 4028012)
21. Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation.
Sladek NE; Doeden D; Powers JF; Krivit W
Cancer Treat Rep; 1984 Oct; 68(10):1247-54. PubMed ID: 6395951
[TBL] [Abstract][Full Text] [Related]
22. Alkylation of guanosine and deoxyguanosine by phosphoramide mustard.
Mehta JR; Przybylski M; Ludlum DB
Cancer Res; 1980 Nov; 40(11):4183-6. PubMed ID: 7471059
[TBL] [Abstract][Full Text] [Related]
23. Covalent binding of 1,2-dihaloalkanes to DNA and stability of the major DNA adduct, S-[2-(N7-guanyl)ethyl]glutathione.
Inskeep PB; Koga N; Cmarik JL; Guengerich FP
Cancer Res; 1986 Jun; 46(6):2839-44. PubMed ID: 2870801
[TBL] [Abstract][Full Text] [Related]
24. Comparative disposition of phosphoramide mustard and other cyclophosphamide metabolites in the mouse using the Salmonella/mutagenesis assay.
Suling WJ; Struck RF; Woolley CW; Shannon WM
Cancer Treat Rep; 1978 Sep; 62(9):1321-8. PubMed ID: 356985
[No Abstract] [Full Text] [Related]
25. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene.
Koc H; Tretyakova NY; Walker VE; Henderson RF; Swenberg JA
Chem Res Toxicol; 1999 Jul; 12(7):566-74. PubMed ID: 10409395
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
Erickson LC; Ramonas LM; Zaharko DS; Kohn KW
Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062
[TBL] [Abstract][Full Text] [Related]
27. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione.
Dirven HA; van Ommen B; van Bladeren PJ
Cancer Res; 1994 Dec; 54(23):6215-20. PubMed ID: 7954469
[TBL] [Abstract][Full Text] [Related]
28. Formation of a phosphoramide mustard-nucleotide adduct that is not by alkylation at the N7 position of guanine.
Maccubbin AE; Caballes L; Chheda GB; Struck RF; Gurtoo HL
Biochem Biophys Res Commun; 1989 Sep; 163(2):843-50. PubMed ID: 2783126
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of hydrolysis in vitro of nornitrogen mustard, a metabolite of phosphoramide mustard and cyclophosphamide.
Hemminki K; Alhonen A; Linkola E; Hesso A
Arch Toxicol; 1987 Dec; 61(2):126-30. PubMed ID: 3439884
[TBL] [Abstract][Full Text] [Related]
30. Cross-linking of DNA in L1210 cells and nuclei treated with cyclophosphamide and phosphoramide mustard.
Surya YA; Rosenfeld JM; Hillcoat BL
Cancer Treat Rep; 1978 Jan; 62(1):23-9. PubMed ID: 564237
[TBL] [Abstract][Full Text] [Related]
31. Role of apoptosis in mediating phosphoramide mustard-induced rat embryo malformations in vitro.
Chen B; Cyr DG; Hales BF
Teratology; 1994 Jul; 50(1):1-12. PubMed ID: 7974249
[TBL] [Abstract][Full Text] [Related]
32. Covalent binding of benzidine and N-acetylbenzidine to DNA at the C-8 atom of deoxyguanosine in vivo and in vitro.
Martin CN; Beland FA; Roth RW; Kadlubar FF
Cancer Res; 1982 Jul; 42(7):2678-86. PubMed ID: 7083160
[TBL] [Abstract][Full Text] [Related]
33. Stabilities of 7-alkylguanosines and 7-deoxyguanosines formed by phosphoramide mustard and nitrogen mustard.
Kallama S; Hemminki K
Chem Biol Interact; 1986 Jan; 57(1):85-96. PubMed ID: 3948286
[TBL] [Abstract][Full Text] [Related]
34. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
Wang YP; Yan J; Fu PP; Chou MW
Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
[TBL] [Abstract][Full Text] [Related]
35. Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions.
Gilard V; Martino R; Malet-Martino M; Niemeyer U; Pohl J
J Med Chem; 1999 Jul; 42(14):2542-60. PubMed ID: 10411475
[TBL] [Abstract][Full Text] [Related]
36. The partitioning of phosphoramide mustard and its aziridinium ions among alkylation and P-N bond hydrolysis reactions.
Shulman-Roskes EM; Noe DA; Gamcsik MP; Marlow AL; Hilton J; Hausheer FH; Colvin OM; Ludeman SM
J Med Chem; 1998 Feb; 41(4):515-29. PubMed ID: 9484502
[TBL] [Abstract][Full Text] [Related]
37. Thermodynamic analysis of the reaction of phosphoramide mustard with protector thiols.
Seitz DE; Katterjohn CJ; Rinzel SM; Pearce HL
Cancer Res; 1989 Jul; 49(13):3525-8. PubMed ID: 2499418
[TBL] [Abstract][Full Text] [Related]
38. Studies on the selective action of cyclophosphamide (NSC-26271): Inactivation of the hydroxylated metabolite by tissue-soluble enzymes.
Cox PJ; Phillips BJ; Thomas P
Cancer Treat Rep; 1976 Apr; 60(4):321-6. PubMed ID: 179712
[TBL] [Abstract][Full Text] [Related]
39. Effect of butylated hydroxyanisole, alpha-angelica lactone, and beta-naphthoflavone on benzo(alpha)pyrene:DNA adduct formation in vivo in the forestomach, lung, and liver of mice.
Ioannou YM; Wilson AG; Anderson MW
Cancer Res; 1982 Apr; 42(4):1199-204. PubMed ID: 7059996
[TBL] [Abstract][Full Text] [Related]
40. Covalent sequestration of phosphoramide mustard by metallothionein--an in vitro study.
Wei D; Fabris D; Fenselau C
Drug Metab Dispos; 1999 Jul; 27(7):786-91. PubMed ID: 10383921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
